Literature DB >> 3058901

Pulmonary vascular resistance and the risk of heart transplantation.

J K Kirklin1, D C Naftel, J W Kirklin, E H Blackstone, C White-Williams, R C Bourge.   

Abstract

Elevated pulmonary vascular resistance was an incremental risk factor for premature death after heart transplantation (p = 0.0002). Its effect was continuously variable and not dichotomous (yes or no). The rate of rise in risk of death corresponded quite evenly to the progressive increase in pulmonary vascular resistance from low to high values, rather than abruptly increasing at a certain point. This effect was incremental to the risk imposed by congenital heart disease (in contrast to idiopathic or ischemic cardiomyopathy). Expression of the pulmonary vascular resistance in units times square meters provides more accurate predictions than expression in Wood units (p for difference = 0.03).

Entities:  

Mesh:

Year:  1988        PMID: 3058901

Source DB:  PubMed          Journal:  J Heart Transplant        ISSN: 0887-2570


  18 in total

1.  Clinical research priorities in adult congenital heart disease.

Authors:  Timothy Cotts; Paul Khairy; Alexander R Opotowsky; Anitha S John; Anne Marie Valente; Ali N Zaidi; Stephen C Cook; Jamil Aboulhosn; Jennifer Grando Ting; Michelle Gurvitz; Michael J Landzberg; Amy Verstappen; Joseph Kay; Michael Earing; Wayne Franklin; Brian Kogon; Craig S Broberg
Journal:  Int J Cardiol       Date:  2013-12-24       Impact factor: 4.164

2.  Right Ventricular Dysfunction and Its Contribution to Morbidity and Mortality in Left Ventricular Heart Failure.

Authors:  Amresh Raina; Talha Meeran
Journal:  Curr Heart Fail Rep       Date:  2018-04

3.  New Diagnostic and Therapeutic Strategies for Pulmonary Hypertension Associated with Left Heart Disease.

Authors:  Scott Feitell; Miriam Jacob
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-03

4.  Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension.

Authors:  Pradeep K Nair; Robert L Kormos; Jeffrey J Teuteberg; Michael A Mathier; Christian A Bermudez; Yoshiya Toyoda; Mary Amanda Dew; Marc A Simon
Journal:  J Heart Lung Transplant       Date:  2010-02       Impact factor: 10.247

5.  Multiple risk factors before pediatric cardiac transplantation are associated with increased graft loss.

Authors:  Scott R Auerbach; Marc E Richmond; Jonathan M Chen; Ralph S Mosca; Jan M Quaegebeur; Linda J Addonizio; Daphne T Hsu; Jacqueline M Lamour
Journal:  Pediatr Cardiol       Date:  2011-09-04       Impact factor: 1.655

6.  Severe pulmonary vascular change in patients dying with right ventricular failure after heart transplantation.

Authors:  P S Hasleton; N H Brooks
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

7.  Guidelines for heart transplantation.

Authors:  N de Jonge; J H Kirkels; C Klöpping; J R Lahpor; K Caliskan; A P W M Maat; J Brügemann; M E Erasmus; R J M Klautz; H F Verwey; A Oomen; C H Peels; A E J Golüke; D Nicastia; M A C Koole; A H M M Balk
Journal:  Neth Heart J       Date:  2008       Impact factor: 2.380

8.  Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation.

Authors:  Babak Daftari; Juan Carlos Alejos; Gregory Perens
Journal:  J Transplant       Date:  2010-03-10

Review 9.  Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.

Authors:  Bhavadharini Ramu; Brian A Houston; Ryan J Tedford
Journal:  Curr Heart Fail Rep       Date:  2018-04

10.  Lowering pulmonary wedge pressure after heart transplant: pulmonary compliance and resistance effect.

Authors:  Nádia Moreira; Rui Baptista; Susana Costa; Fátima Franco; Mariano Pêgo; Manuel Antunes
Journal:  Arq Bras Cardiol       Date:  2015-07-31       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.